Skip to main content
Premium Trial:

Request an Annual Quote

Michael Little

Natera has appointed Michael Little as senior vice president of research and development. Prior to Natera, Little was the global head of diagnostics development at Novartis. Before that, he served as vice president of research and development, vice president of medical affairs, vice president of regulatory and scientific affairs, and the vice president of program management at Novartis Diagnostics.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.